Teva Pharmaceutical Industries Ltd financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Industry
Pharmaceutical Preparations
Location
Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi'a St., Tel Aviv, Israel
State of incorporation
Israel
Fiscal year end
December 31
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (to 1/16/2001)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 92.2 % -11.7%
Quick Ratio 30 % -16%
Debt-to-equity 517 % +9.07%
Return On Equity -13.4 % +53.8%
Return On Assets -2.26 % +58%
Operating Margin 2.87 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.13B shares +1.08%
Entity Public Float 8.38B USD +14.8%
Common Stock, Value, Issued 58M USD +1.75%
Weighted Average Number of Shares Outstanding, Basic 1.13B shares +1.07%
Weighted Average Number of Shares Outstanding, Diluted 1.13B shares -0.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16.8B USD +9.82%
Research and Development Expense 54M USD
Selling and Marketing Expense 2.5B USD +10%
General and Administrative Expense 1.15B USD -0.78%
Operating Income (Loss) 482M USD -115%
Nonoperating Income (Expense) -1.01B USD +3.89%
Income Tax Expense (Benefit) 687M USD +574%
Net Income (Loss) Attributable to Parent -958M USD +58.8%
Earnings Per Share, Basic -0.84 USD/shares +59.8%
Earnings Per Share, Diluted -0.84 USD/shares +59.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.32B USD +47.6%
Accounts Receivable, after Allowance for Credit Loss, Current 3.46B USD +2.28%
Inventory, Net 3.96B USD -2.27%
Other Assets, Current 445M USD -14.4%
Assets, Current 12.3B USD +7.78%
Deferred Income Tax Assets, Net 2.07B USD +17.9%
Property, Plant and Equipment, Net 5.67B USD +0.89%
Operating Lease, Right-of-Use Asset 364M USD -10.3%
Goodwill 16.1B USD -4.51%
Other Assets, Noncurrent 459M USD -3.77%
Assets 41.8B USD -0.8%
Employee-related Liabilities, Current 619M USD +16.8%
Liabilities, Current 13.8B USD +21.1%
Operating Lease, Liability, Noncurrent 295M USD -8.95%
Other Liabilities, Noncurrent 4.34B USD +9.98%
Liabilities 35.4B USD +1.92%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.77B USD +4.85%
Retained Earnings (Accumulated Deficit) -15B USD -6.87%
Stockholders' Equity Attributable to Parent 6.07B USD -12.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.38B USD -13.6%
Liabilities and Equity 41.8B USD -0.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.86B USD +60.4%
Net Cash Provided by (Used in) Financing Activities -1.69B USD +17.4%
Net Cash Provided by (Used in) Investing Activities 891M USD +6.58%
Common Stock, Shares Authorized 2.5B shares 0%
Common Stock, Shares, Issued 1.24B shares +1.06%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.07B USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.32B USD +47.5%
Deferred Tax Assets, Valuation Allowance 3.01B USD -2.05%
Deferred Tax Assets, Gross 1.81B USD +24.3%
Operating Lease, Liability 417M USD -5.66%
Payments to Acquire Property, Plant, and Equipment 119M USD -6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -813M USD +61.1%
Lessee, Operating Lease, Liability, to be Paid 496M USD -8.66%
Property, Plant and Equipment, Gross 11.4B USD +1.16%
Operating Lease, Liability, Current 320M USD -8.31%
Lessee, Operating Lease, Liability, to be Paid, Year Two 98M USD +4.26%
Lessee, Operating Lease, Liability, to be Paid, Year One 116M USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 80M USD +1.27%
Unrecognized Tax Benefits 651M USD +2.04%
Lessee, Operating Lease, Liability, to be Paid, Year Four 62M USD -6.06%
Additional Paid in Capital 27.9B USD +0.29%
Amortization of Intangible Assets 588M USD -6.22%